A new generation of blood vessels?

The HRI’s Applied Materials Group is working to develop the next generation of bioactive materials – materials that can bond to living tissues. 

It is hoped that this will provide better treatment options for people living with cardiovascular disease. 

One of these projects involves looking into the use of silk (yes, from silk worm cocoons) as a material for the engineering of artificial blood vessels. 

Elysse Filipe began this study as part of her PhD project, and is optimistic about where it could lead. 

‘If successful, this could revolutionise the treatment of coronary artery disease,’ says Elysse.

‘Current treatments use blood vessels harvested from the arms and legs of the patients, which are then implanted around the heart to improve coronary blood flow. However in many cases, the use of the patients own vessels is not recommended due to pre-existing vessel disease, advanced age or even because the vessels have already been used for something else. There is currently no 'off-the-shelf’ alternative for these patients. If I am able to create an artificial blood vessel in the lab, it would allow treatment for coronary artery disease without having to use the patient’s own vessels’ she adds.

Previous
Next

Related news

Meet the team: Bob Lee

Originally from Christchurch, New Zealand, Bob Lee has experienced the research environment on both sides of the Tasman Sea. But while his life is currently in Sydney, Australia where the HRI is based, the ties to home remain strong for Bob. 

Read more

Gout Drug Mends Broken Hearts

A drug used to treat arthritis has been found to clear clogged arteries in heart attack survivors, world-first HRI research shows.

The landmark discovery by Associate Professor Sanjay Patel, Leader of the Cell Therapeutics Group, and his team at the HRI paves the way for a cheap, simple and effective treatment regime that could protect thousands of heart patients from future attacks that might kill them or further damage their heart. 

Read more

Stopping atherosclerosis in its tracks

A new treatment for atherosclerosis could soon be in sight, with an HRI study finding that progression of the common condition could be slowed using the chemokine binding protein ‘M3’.
Read more